Albendazole Drugs Market: Rise in Awareness about Veterinary Care to Drive the Market - BioSpace

Albany NY, United States: Albendazole is an anthelmintic medication, also known as albendazolum. It prevents newly hatched insect larvae (worms) from growing or multiplying in the body. It is used to treat certain infections caused by worms such as pork tapeworm and dog tapeworm. Albendazole can be used in humans and animals for various indications. In animals, it is used to treat capillariasis caused by Capillaria plica (dogs and cats) and C. felis cati (cats). Capillaria infect the urinary bladder, hence are often called bladder worms. Additionally, albendazole has been used to treat Filaroides infections and Giardia infections in dogs.

Read Report Overview - https://www.transparencymarketresearch.com/albendazole-drugs-market.html

Albendazole leads to degeneration alterations in the tegument and intestinal cells of the worm by diminishing its energy production, consequently leading to immobilization and death of the parasite. It binds to the colchicine-sensitive site of tubulin, thereby inhibiting its polymerization or assembly into microtubules.

Key Drivers and Opportunities of Global Albendazole Drugs Market

• Helminthiasis, also known as worm infection, is a macroparasitic disease of humans and other animals, in which a part of the body is infected with parasitic worms, known as helminths. Rise in prevalence of helminths infections caused by roundworm, hookworm, whipworm, and others worms is projected to drive the demand for anthelmintic drugs for the treatment. This in turn is anticipated to boost the growth of the global market. For instance, in August 2018, 12 cases of Angiostrongylus cantonensis, also known as rat lungworm, were reported in the U.S.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79401

• According to the CDC, 2,800 cases of Angiostrongylus cantonensis across 30 countries were reported in 2018. According to CDC estimates, 576 million to 740 million people in the world were infected with hookworm in 2019. In the U.S., the hookworm, ascaris, and whipworm infections have been eradicated and not found in the country. The above helminth infections were estimated to be prevalent only in South Eastern U.S. until the 20th century. According to the Companion Animal Parasite Council (CAPC), estimated roundworm and hookworm infection in dogs was 141,166 and 238,947; in cats it was 65,316 and 10,832, respectively, in 2019.
• Rise in awareness about veterinary care increases the level of control and care of animals. This leads to an increase in number of animals. Moreover, changes in veterinary education over the last few decades have placed greater emphasis on animal welfare, owing to rise in awareness about animal health care. Hence, increase in awareness about veterinary care is likely boost the growth of the global market.
• Government and private sector organizations are engaged in spreading awareness about the importance of animal care. For instance, the American Animal Hospital Association is a non-profit organization for companion animal veterinary hospitals. It is an accrediting body for small animal hospitals in the U.S. and Canada. Hence, rise in awareness about veterinary care and government initiatives are likely augment the global market.

Request for Analysis of COVID-19 Impact on Albendazole Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79401

• Developing countries present lucrative opportunities in the albendazole drugs market, as the prevalence of helminthic infection is high in developing regions such as Asia, Africa, and Latin America. Moreover, modernization toward improving health care infrastructure is likely to create opportunities in the market.

North America to Capture Major Share of Global Albendazole Drugs Market

• North America is projected to account for major share of the global albendazole drugs market due to focus on research & development by key players. For instance, the U.S. Food and Drug Administration has approved Cipla's Abbreviated New Drug Application for Albendazole Tablets.
• The albendazole drugs market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to increase in awareness and rise in prevalence of helminthic infection

Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79401

Key Players Operating in Global Albendazole Drugs Market

• The global albendazole drugs market is highly consolidated due to the presence of small number of key players. These players hold major market share in their respective regions. Demand for anthelmintic products has increased in emerging as well as developed markets. For instance, GlaxoSmithKline plc donated 9 billion Albendazole tablets to the WHO, with 890 million alone donated by 2019. This drug is likely to tackle and eradicate lymphatic filariasis (LF) and intestinal worms (soil-transmitted helminths) disease. The company plans to offer Albendazole tablets until the eradication of neglected tropical diseases (NTDs) in developing countries. Growth strategies adopted by leading players are likely to drive the global market.

Major players operating in the global albendazole drugs market are:

• GlaxoSmithKline plc
• CiplaMed (Cipla)
• Lupin
• Amneal Pharmaceuticals LLC
• Ben Pharmaceuticals
• Healthy Life Pharma Private Limited

Browse more Reports by Transparency Market Research:

Digital Pathology Market: Digital pathology market is currently booming owing to rise in research and development activities. Surge in incidence and prevalence of chronic diseases and demand for advanced therapeutics are leading to increase in demand for new drugs and medicines. This in turn is increase in focus of research and development.

Oligonucleotide Therapeutics Market: The global oligonucleotide therapeutics market is marked with presence of quite a few prominent players, thereby making it a fairly competitive market for both the existing players and new entrants. These companies are forging, partnerships, collaborations, and mergers in an effort to gain larger revenue and market share.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Adblock test (Why?)